Akiko Miyashita

Akiko Miyashita

Director/Board Member at
U.S.-Japan Council

Net worth: 2 M $ as of 29/09/2026

70 year
Technology Services
Health Technology
Consumer Services

Profile

Ms. Akiko M.
Miyashita is a Chief Strategy Officer at Valo Health LLC.
She is on the Board of Directors at Averin Capital Acquisition Corp.
and U.S.-Japan Council.
Ms. Miyashita was previously employed as an Independent Director by Halozyme Therapeutics, Inc., an Independent Director by EMI, Inc., a Partner by Innosight Consulting LLC, a Vice President-Corporate Development by International Business Machines Corp., and a Trustee by The Children's Hospital of Philadelphia Foundation.
She received her undergraduate degree from The Leeds School of Business and an MBA from Daniels College of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
08/03/2026 20,772 ( 0.02% ) 2 M $ 29/09/2026

Akiko Miyashita active positions

CompaniesPositionStart
Director/Board Member -
Corporate Officer/Principal 30/04/2019

Former positions of Akiko Miyashita

CompaniesPositionEnd
HALOZYME THERAPEUTICS, INC. Director/Board Member 04/05/2026
Director/Board Member 27/04/2015
Corporate Officer/Principal 31/12/2014
IBM Corporate Officer/Principal 31/12/2010
Director/Board Member -
See the detail of Akiko Miyashita's experience

Education of Akiko Miyashita

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Technology Services

Health Technology

Health Technology

Commercial Services

Health Services

Technology Services

Consumer Services

Consumer Services

Technology Services

  1. Stock Market
  2. Insiders
  3. Akiko Miyashita